Work

Figure S1 from A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder

Year: 2025

Type: other

Abstract: 12-CK Score from RNA Sequencing

DOI: 10.1158/1078-0432.30708429

Authors: Roger Li, Wade J. Sexton, Jasreman Dhillon, Anders Berglund, Shreyas Naidu, Gustavo Borjas, Kyle Rose, Youngchul Kim, Xuefeng Wang, Jose R. Conejo-Garcia, Rohit K. Jain, Michael A. Poch, Philippe E. Spiess, Julio Pow-Sang, Scott M. Gilbert, Jingsong Zhang

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4416671095

Cites:

Cited by:

Related to: 10